Fundraising Fox
/People
Sign in

Stan Froehner

Founder

CFO, Chairman, and Co-Founder at Myosana Therapeutics

Seattle, Washington, United States

FoundedMyosana Therapeutics

Find your path to Stan

99 people in our graph can introduce you to Stan.

Sign up to see every warm intro you have to Stan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Stan. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Stan Froehner is Co-Founder and Chairman of the Board of Myosana Therapeutics, Inc., a company developing non-viral gene therapies for Duchenne muscular dystrophy (DMD). The company's proprietary platform is designed to deliver genes of varying sizes to skeletal and cardiac muscle, including full-length dystrophin for individuals with DMD.

CFO, Chairman, and Co-Founder at Myosana Therapeutics

Co-founders at Myosana Therapeutics

NWNick Whitehead
Nick WhiteheadCEO, CSO & Co-Founder

Experience

  1. Myosana Therapeutics, IncCo-Founder and Chairman of the Boardcurrent2018 — presentSeattle, Washington, United States
  2. University of WashingtonUW Medicine Distinguished Professorcurrent2019 — presentGreater Seattle Area
  3. UW MedicineProfessor and Chair2000 — 2020University of Washington School of Medicine
  4. University of North Carolina at Chapel HillProfessor and Chair1992 — 2000
  5. Dartmouth Medical SchoolProfessor of Biochemistry1978 — 1991

Skills & more

Molecular Biology9Grant Writing1Biochemistry5Neuroscience2Medical Education1Cell Biology6Lifesciences1Research1Program EvaluationScience2Genetics1Cell1
+6 moreFluorescence MicroscopyCell CultureHigher EducationLife SciencesWestern BlottingImmunohistochemistry

From Stan's professional profile.

Frequently asked questions

Who is Stan Froehner?
Stan Froehner is Co-Founder and Chairman of the Board of Myosana Therapeutics, Inc., a company developing non-viral gene therapies for Duchenne muscular dystrophy (DMD). The company's proprietary platform is designed to deliver genes of varying sizes to skeletal and cardiac muscle, including full-length dystrophin for individuals with DMD.
Where does Stan Froehner work?
Stan Froehner is CFO, Chairman, and Co-Founder of Myosana Therapeutics.
What companies did Stan Froehner found?
Stan Froehner founded Myosana Therapeutics.
Where did Stan Froehner go to school?
Stan Froehner studied at Harvard Medical School (Postdoctoral Research, Neurobiology and Neurosciences); Caltech (Doctor of Philosophy (PhD), Biochemistry and Neurophysiology); The University of Texas at Austin (Bachelor of Science (BS), Chemistry).

Founder mafias

Same school

Shared employers

Also worked at Myosana Therapeutics, Inc1

Matthew LumleyChief Medical Advisor at Myosana Therapeutics